Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Center for Clinical Pharmacology Research (BCCPR) is a leading Chinese contract research organization (CRO) specializing in early-phase clinical development and clinical pharmacology services. Established in 1983 and affiliated with the prestigious Peking Union Medical College Hospital (PUMCH), it was the first professional institution in China dedicated to clinical pharmacology research. The center provides a comprehensive suite of services, including Phase I-IV clinical trial management, bioequivalence (BE) studies, and advanced pharmacokinetic/pharmacodynamic (PK/PD) analysis. BCCPR is highly regarded for its technical expertise and adherence to international Good Clinical Practice (GCP) standards, serving as a critical partner for pharmaceutical companies navigating the drug approval process in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Clinical Pharmacology Research Bdbeq.